A Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Eltrombopag (Primary) ; Antithymocyte globulin; Ciclosporin
- Indications Aplastic anaemia
- Focus Therapeutic Use
- Acronyms RACE
- 15 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 02 Apr 2015 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020 as reported by ClinicalTrials.gov record.
- 02 Apr 2015 Planned initiation date changed from 1 Jun 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.